“SourceBio has built a strong balance sheet with substantial cash resources. It is now well positioned to accelerate growth in its core business units, Healthcare Diagnostics and Genomics – both organic and inorganic. It’s an exciting time for our business and we look forward to executing on our ambitious growth plans and delivering value to our shareholders.”

Executive Chairman, SourceBio International